Skip to content

A Study to Evaluate the Safety of Long Term Consumption of Food Containing Plant Extract.

A Study to Evaluate the Safety of Long Term Consumption of Food Containing Plant Extract. - A Study to Evaluate the Safety of Long Term Consumption of Food Containing Plant Extract.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000026285
Enrollment
15
Registered
2017-02-26
Start date
2017-02-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adult (including borderline diabetes)

Interventions

Test food containing plant extract, 12 weeks consumption.

Sponsors

Oneness support Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) 20<=Age=<64 of healty men and women (2) Subjects who are judged as normoglycemic or borderline diabetes by the investigator (3) Subjects who can make self-judgments and voluntarily give written informed consents

Exclusion criteria

Exclusion criteria: (1) Subjects with a medical history of diabetes, liver disease, kidney disease, gastrointestinal disease, peripheral vascular disease, or severe diseases (2) Subjects with a disorder in heart and lung function (3) Subjects with abnormal parameters in liver or kidney function (4) Subjects who had a gastrointestinal surgery (5) Subjects with a disease currently under treatment (6) Subjects with drug or food allergies (7) Subjects with anemic (8) Subjects who play high intensity sports or are on a diet (9) Subjects who are taking supplemental foods, quasi drugs or drug products (including OTC or prescribed medication) containing ingredient of test food (10) Subjects who drink excessive alcohol, or who cannot stop drinking alcohol at one day prior to the test day and the day of the test (11) Subjects who have been pregnant or subjects who have a plan to become pregnant or breast feed during the study period (12) Subjects who is participating in other studies or planning to participate during the study period (13) Subjects who are deemed unsuitable by the investigator for other reasons

Design outcomes

Primary

MeasureTime frame
Inquiry, physical examination, medical examination by hematology,blood biochemistry, urinalysis.

Countries

Japan

Contacts

Public ContactMakoto Terashima

Oneness support Co., Ltd. Clinical trial Division

mterashima@oneness-sup.co.jp06-4801-8917

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026